European Respiratory Society
Occupational and Environmental Lung Disease

This Monograph provides the general respiratory physician with a working reference based on the latest literature and expert opinion. The initial chapter provides a contemporaneous global perspective of the epidemiology of occupational and environmental lung diseases in an ever-evolving landscape. The book then goes on to consider specific occupational lung diseases. Each chapter has a clear clinical focus and considers: key questions to ask in the history; appropriate investigations to undertake; differential diagnoses; and management. Controversies or diagnostic conundrums encountered in the clinic are also considered, and further chapters are more broadly centred on the non-workplace environment; specifically, the respiratory symptoms and diseases associated with both the outdoor and indoor environments.

  1. Page vi
  2. Page vii
  3. Page ix
  4. Page 1
    Abstract
    Mohamed F. Jeebhay, Occupational Medicine Division and Centre for Environmental & Occupational Health Research, School of Public Health and Family Medicine, University of Cape Town, Room 4.45, Fourth Level, Falmouth Building, Anzio Road, Observatory 7925, Cape Town, South Africa. E-mail: Mohamed.Jeebhay@uct.ac.za

    Workplace exposures contribute substantially to the burden of chronic lung disease in adults. Occupational lung diseases contributing to the greatest disease burden, mortality and disability globally include COPD (caused by particulate dusts, vapours, fumes and second-hand tobacco smoke), lung cancer and mesothelioma (commonly due to asbestos), work-related asthma, pneumoconioses (silicosis, coal worker's pneumoconiosis, asbestosis) and occupational infections (pulmonary tuberculosis in silica-exposed and healthcare workers, community-acquired pneumonia). Despite the decrease in per capita disease burden globally over the past two decades, this burden is not shared equitably across regions. It is influenced by rapid economic transition and population growth, unregulated economies, a burgeoning informal sector and inadequate exposure control, as well as poor access to the knowledge and resources to achieve good control of workplace respiratory hazards. Increased physician awareness, diligent disease investigation and regular reporting, as well as ongoing surveillance, will contribute to improved detection and management of occupational lung diseases.

    Cite as: Jeebhay MF. The global perspective of occupational lung disease. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 1–18 [https://doi.org/10.1183/2312508X.10034019].

  5. Page 19
    Abstract
    Martie van Tongeren, University of Manchester, Ellen Wilkinson Building, Oxford Road, Manchester, M13 9PL, UK. E-mail: Martie.j.van-tongeren@manchester.ac.uk

    Practicing respiratory physicians are very likely to see patients with work-related respiratory diseases. It is important for the physician to be aware of potential occupational risk factors that may contribute to the development of the disease or the symptoms. It will not always be easy to obtain a reliable and comprehensive assessment of the occupational exposure (current or past). However, a large volume of information and data is available that can assist the physician in determining the likelihood and level of exposure to hazardous agents in the workplace. Such information should be carefully considered and experts, such as occupational hygienists, can be enlisted to assist with the assessment of exposure, e.g. to identify occupational hazards and estimate exposure using exposure tools or carrying out measurement surveys. Information on exposure could support diagnosis and treatment plans and most importantly, might be used to identify the need for intervention to reduce the risk to health for other workers.

    Cite as: Basinas I, Tinnerberg H, van Tongeren M. Exposure assessment. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 19–33 [https://doi.org/10.1183/2312508X.10035919].

  6. Page 34
    Abstract
    Olivier Vandenplas, Dept of Chest Medicine, Centre Hospitalier Universitaire UCL Namur, 1 Avenue G. Therasse, B-5530 Yvoir, Belgium. E-mail: olivier.vandenplas@uclouvain.be

    Sensitiser-induced occupational asthma (OA), like asthma in general, results from the complex interactions between environmental factors and individual susceptibility. Workplace agents causing OA include both high-molecular-weight proteins of animal or vegetal origin that act through a demonstrable IgE-mediated mechanism and low-molecular-weight chemicals for which the immunopathological mechanisms remain poorly elucidated. The diagnostic investigation of OA is based on a stepwise approach that includes a thorough clinical and occupational history, immunological testing, and the assessment of functional parameters and markers of airway inflammation in order to demonstrate the causal relationship between asthma and exposure to a specific workplace agent. Complete and definitive avoidance of exposure to the causative agent remains the optimal treatment, although the rate of full recovery is low, especially when the diagnosis is delayed and the asthma is more severe. The burden of OA is substantial, not only because of its long-term respiratory health consequences but also because of the socioeconomic impact for affected workers, employers and society.

    Cite as: Vandenplas O, Lemière C. Sensitiser-induced occupational asthma. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 34–51 [https://doi.org/10.1183/2312508X.10034119].

  7. Page 52
    Abstract
    Gareth I. Walters, NHS Occupational Lung Disease Service, Birmingham Chest Clinic, 151 Great Charles Street, Birmingham B3 3HX, UK. E-mail: gareth.walters@heartofengland.nhs.uk

    Work-exacerbated asthma (WEA) has a prevalence comparable to that of occupational asthma (OA) and occurs in approximately one-fifth of working adults with asthma. Workplace exposures that exacerbate pre-existing asthma differ somewhat from those of OA and include airway irritants, aeroallergens, environmental conditions, strenuous physical exertion and emotional stress. A diagnosis of WEA has socioeconomic consequences of a magnitude similar to those in OA. Making the distinction between WEA and OA by sensitisation is a challenge but is important, as the management of individual workers and the workplace is likely to be different. There are a number of other asthma mimics, which may show a relationship with work, that also require consideration and exclusion. For the practising clinician, taking a thorough medical and occupational history is of paramount importance, and onward referral to a specialist and further investigation may be necessary. Primary prevention, worker education, optimisation of asthma treatment and tailored measures to reduce workplace exposures may improve outcomes for individuals, although the effectiveness of workplace interventions in reducing the incidence and impact of WEA is unknown.

    Cite as: Walters GI. Work-exacerbated asthma. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 52–69 [https://doi.org/10.1183/2312508X.10034219].

  8. Page 70
    Abstract
    Sherwood Burge, Occupational Lung Disease Unit, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham B9 5ST, UK. E-mail: Sherwood.burge@heartofengland.nhs.uk

    Inhalation injuries can cause acute breathlessness within minutes of exposure or be delayed for days or occasionally weeks. Pathologies range from asphyxiation to acute mucosal injury to ulceration, asthma, pulmonary oedema and fibrosis of the airways or lung parenchyma. Some agents exert their toxicity by systemic effects. Exposures may be from natural disasters such as volcanic eruptions, from fires and industrial accidents, or from terrorist and warfare agents. This chapter classifies acute lung injury by the major site of damage, which is where emergency care should be directed, as the exact agent inhaled is often unknown in the acute situation. In addition, irritant-induced asthmas, both acute and chronic, are discussed.

    Cite as: Burge S. Acute inhalation injury. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 70–85 [https://doi.org/10.1183/2312508X.10034319].

  9. Page 86
    Abstract
    Vivi Schlünssen, Bartholins Alle 2, Bg 1260, 8000 Aarhus C, Aarhus, Denmark. E-mail: vs@ph.au.dk

    COPD, a leading cause of death worldwide, is defined as the presence of a relevant respiratory symptom plus spirometrically proven irreversible airways obstruction in the absence of other diseases. Environmental exposures are the main contributors to COPD and chronic bronchitis. Smoking is the most influential risk factor in high-income countries, whereas biofuel smoke is a major risk factor in low- and middle-income countries. Environmental exposures result in an accelerated decline in lung function. Importantly, environmental exposures early in life including infections and smoking may hamper the maximally attained lung function, resulting in COPD without an accelerated decline in lung function. An important proportion of COPD, chronic bronchitis and bronchiolitis cases are due to occupational exposure to vapour, gases, dust and fumes, and this aspect presents an unsolved challenge for epidemiology and occupational medicine. Knowledge of the impact of specific exposures and exposure levels is urgently needed in order to implement an effective strategy for prevention.

    Cite as: Schlünssen V, Würtz ET, Hansen MRH, et al. The impact on the aetiology of COPD, bronchitis and bronchiolitis. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 86–103 [https://doi.org/10.1183/2312508X.10034419].

  10. Page 104
    Abstract
    Christopher Michael Barber, Centre for Workplace Health, Brearley Outpatients, Northern General Hospital, Herries Road, Sheffield S5 7AU, UK. E-mail: chris.barber4@nhs.net

    Occupational exposures are estimated to account for around one in five cases of hypersensitivity pneumonitis (HP), but making a link between work and disease can be challenging. All working-age patients with unexplained interstitial lung disease (ILD) should routinely be asked whether they have work-related symptoms and screened for exposures to common causes. Occupational HP frequently mimics other common respiratory conditions, particularly asthma, recurrent chest infections and idiopathic forms of ILD (particularly nonspecific interstitial pneumonia and IPF). In some cases, establishing a diagnosis is difficult, requiring careful evaluation of all available clinical data, ideally by an experienced multidisciplinary team. The key aims of management are early identification of the cause and, wherever possible, maintaining employment through workplace interventions that prevent further exposure. Clinical outcomes following cessation of exposure are highly variable but are generally much better for patients without established fibrosis. In addition to the management of the individual, it is also important to ensure that any other affected co-workers are identified as soon as possible and that control measures are reviewed to prevent further cases of disease.

    Cite as: Barber CM, Barnes H. Occupational hypersensitivity pneumonitis. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 104–124 [https://doi.org/10.1183/2312508X.10034519].

  11. Page 125
    Abstract
    Fraser J.H. Brims, Curtin Medical School, Curtin University, Kent Street, Bentley, GPO Box U1987 Perth, Western Australia 6856, Australia. E-mail: Fraser.Brims@curtin.edu.au This chapter has supplementary material available from books.ersjournals.com

    Asbestos fibres pose a particular risk for several diseases of the lung and pleura that persist many decades after exposure. Asbestosis refers specifically to the interstitial fibrosis caused by asbestos fibres. The pattern of asbestos use has changed dramatically over time, with significantly less use in developed countries but continued and even increasing use in developing countries. Asbestosis is largely nonspecific in its clinical presentation, and diagnosis is heavily reliant on a detailed occupational history and radiological findings. While there is no known threshold of exposure below which an individual will not develop asbestosis, there is clear evidence for a dose–response relationship in the development of the disease. Treatment is currently limited to supportive measures, although antifibrotic therapies are being evaluated for effectiveness. There is raised risk for lung cancer. The changing global use of asbestos, coupled with advances in imaging technology facilitating screening and advances in the genetic understanding of asbestosis, make this an emerging area of clinical research.

    Cite as: Bennett K, Brims FJH. Asbestosis. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 125–140 [https://doi.org/10.1183/2312508X.10034619].

  12. Page 141
    Abstract
    Jennie Hui, School of Population and Global Health, The University of Western Australia, 35 Stirling Highway, Perth WA 6009, Australia. E-mail: Jennie.Hui@health.wa.gov.au

    Pleural disease resulting from asbestos exposure is a consequence of the physical characteristics of the fibres that determine their deposition and persistence in the subpleural alveoli resulting in both benign and malignant changes. The diameter of fibres permits them to enter the alveoli in the laminar flow of peripheral airways, but their long axis prevents their phagocytosis by macrophages that are responsible for clearance of the non-conducting airspaces of the lungs. The value of asbestos in industry is a result of its indestructability. The consequent persistence of asbestos fibres in the lung promotes ongoing inflammatory responses (pleural plaques, benign asbestos pleural effusion and diffuse pleural fibrosis) and neoplasia (malignant pleural mesothelioma).

    Cite as: Musk AW, Hui J. Non-malignant pleural disease from asbestos and malignant pleural mesothelioma. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 141–149 [https://doi.org/10.1183/2312508X.10034719].

  13. Page 150
    Abstract
    Deborah Helwen Yates, Dept of Thoracic Medicine, St Vincent's Hospital, 406 Victoria Street, Darlington, Sydney 2052, New South Wales 2010, Australia. E-mail: deborahy88@hotmail.com This chapter has supplementary material available from books.ersjournals.com

    Despite lower regulated occupational dust exposure levels, silicosis still occurs worldwide as a result of new exposures, a lack of awareness about hazards and poor dust-control practices. This chapter summarises the current situation regarding silicosis and silica-related diseases, including an update on artificial stone silicosis, a newly emerging type of rapidly progressive silicosis. Silica exposure is relevant to more lung diseases in day-to-day respiratory practice than is often appreciated. In addition to silicosis, silica exposure plays a role in sarcoidosis, connective tissue diseases, tuberculosis, lung cancer, COPD and some types of pulmonary fibrosis. A summary of these different diseases is presented, aimed at updating the general respiratory physician. The chapter also outlines the many occupations where silica/silicate exposure may occur and which need to be considered when taking a thorough occupational history, and discusses differential diagnoses, clinical features, investigation and treatment. Although silicosis is currently viewed as untreatable, there are likely to be useful treatment options in the near future.

    Cite as: Yates DH, Johnson AR. Silicosis and other silica-related lung disorders. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 150–175 [https://doi.org/10.1183/2312508X.10034819].

  14. Page 176
    Abstract
    Leonard H.T. Go, Dept of Medicine, Northwestern University Feinberg School of Medicine, 1603 W. Taylor Street, Chicago, IL 60612, USA. E-mail: lgo2@uic.edu This chapter has supplementary material available from books.ersjournals.com

    Coal mine dust lung diseases (CMDLDs) are entirely preventable, yet they continue to occur and are on the rise in some countries. While most physicians think of coal worker's pneumoconiosis as the sole manifestation of coal mine dust exposure, it is now well known that respirable coal mine dust causes a broad spectrum of respiratory diseases, including obstructive lung diseases such as chronic bronchitis and emphysema, as well as pulmonary fibrosis. In order to make an accurate diagnosis and determine the risk of disease progression, physicians must obtain a detailed occupational and exposure history from coal mine workers who present with lung disease. CMDLD is incurable and difficult to treat. Therefore, the greatest focus should be placed on primary prevention by limiting coal mine dust exposure, followed by secondary prevention through periodic medical surveillance with chest imaging and physiological screening.

    Cite as: Go LH, Cohen RA. Coal mine dust lung disease. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 176–189 [https://doi.org/10.1183/2312508X.10034919].

  15. Page 190
    Abstract
    Jennifer Louise Hoyle, North Manchester General Hospital, Delauneys Road, Crumpsall, Manchester M8 5RB, UK. E-mail: Jennifer.hoyle@pat.nhs.uk This chapter has supplementary material available from books.ersjournals.com

    This chapter summarises the effect that inhalation of inorganic dusts has on the lungs (excluding silica and asbestos, which are discussed elsewhere). Metals and metal oxides are discussed according to their likelihood of causing lung fibrosis in their pure form; those where there is greater debate or evidence are discussed in greater detail. Minerals are discussed in a similar way, finishing with a brief discussion of man-made vitreous fibres.

    Cite as: Hoyle JL. Pneumoconiosis and interstitial lung diseases caused by inorganic dust. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 190–210 [https://doi.org/10.1183/2312508X.10035019].

  16. Page 211
    Abstract
    David Fishwick, Centre for Workplace Health, Health and Safety Executive, Harpur Hill, Buxton, Derbyshire SK17 9JN, UK. E-mail: d.fishwick@sheffield.ac.uk

    Inhaled cotton dust remains an important workplace hazard globally and is associated with the risks of byssinosis and accelerated lung function decline. The former is typified by chest tightness that is worse on the first working day and improves as the week progresses, while the latter may lead to airways obstruction. Traditional industrial activities such as waste disposal and relatively newer activities such as the handling of pre-combustion biomass fuels have both been associated with lung problems. Mill fever, Pontiac fever (probably predominantly caused by a noninfectious response to Legionella pneumophilia and possibly endotoxin) and organic dust toxic syndrome are a set of similar systemic responses to microbiological agents inhaled at work. Exposures to metal and polymer fume produce similar preventable systemic responses, normally associated with fever, although the mechanisms are yet to be fully elucidated. Organising pneumonia is an unusual condition that has been linked to various occupational jobs including textile sprayers and biocide users. Thus, bioaerosols, metals and polymers are associated with a variety of potentially preventable short- and longer-latency respiratory illnesses.

    Cite as: Fishwick D. Cotton, other bioaerosols, inhalation fevers and occupational organising pneumonia. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 211–226 [https://doi.org/10.1183/2312508X.10035119].

  17. Page 227
    Abstract
    Dept of Occupational and Environmental Medicine, Imperial College London, Emmanuel Kaye Building, 1b Manresa Road, London, SW3 6LR, UK. E-mail: Joanna.szram@imperial.ac.uk

    Occupational metal exposures are a cause of granulomatous lung disease; the most commonly reported is chronic beryllium disease. Traditionally seen in manufacturing workers in high-income countries, it is likely that increasing exposures will occur in the recycling industries in low- and middle-income countries. Other metals found to cause lung disease are cobalt (also a recognised respiratory sensitiser) and zirconium, metallic elements that are used in a variety of industries and also encountered during reclamation work, due to their high value. Both may cause hard metal lung disease. Finally, one of the pulmonary sequelae of the World Trade Center disaster is an excess incidence of granulomatous lung disease – the reasons for this remain unclear.

    Cite as: Szram J. Granulomatous and allied disorders. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 227–237 [https://doi.org/10.1183/2312508X.10035219].

  18. Page 238
    Abstract
    Dept of Occupational and Environmental Respiratory Disease, National Heart and Lung Institute, Emmanuel Kaye Building, 1B Manresa Road, London SW3 6LR, UK. E-mail: drmartincosgrove@fastmail.fm

    Welding exposes the welder and potentially others in the workplace to particulate metal fume and secondary pollutant gases such as NOx, CO and ozone. There is agreement that welding increases the risk of chronic productive cough, pneumonia and lung cancer, and may cause occupational asthma. There has been a long-standing debate about whether welding causes an accelerated decline in lung function, but recent research and systematic reviews suggest that this is not the case; rather, the long-term effect of welding at high concentrations of fume exposure is a form of pulmonary fibrosis, possibly an occupational respiratory bronchiolitis leading to desquamative interstitial pneumonia. There is a synergistic effect of smoking and welding on nonmalignant respiratory disease, in particular accelerated lung function decline, and therefore welders should be strongly encouraged not to smoke.

    Cite as: Cosgrove MP. Interstitial lung disease in welders. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 238–251 [https://doi.org/10.1183/2312508X.10035319].

  19. Page 252
    Abstract
    Pierluigi Cocco, Dept of Medical Sciences and Public Health, University of Cagliari, Cagliari, SS 554, km 4,500, 09042 Monserrato, Cagliari, Italy. E-mail: pcocco@unica.it

    According to most estimates, occupational exposures are responsible for ∼15% of lung cancer cases, but only a fraction of the cases attributable to an occupational origin are correctly identified clinically. International agencies provide lists of the responsible agents and work processes, as well as guidelines on the diagnostic criteria for work-related lung cancer cases. These include a detailed clinical assessment, a definition of the exposure scenario that is as accurate as possible, a duration of exposure sufficient to reach a cumulative dose capable of inducing biological effects and a latency time consistent with the natural history of the disease. However, threshold levels of occupational exposures to establish a causal link should be considered with flexibility, as they originate from studies on high-level past exposures and/or from comparisons with elevated rates in the general population in times when the smoking toll was heaviest. Major efforts are warranted at international and national levels to upgrade the diagnostic ability to detect occupational lung cancer cases.

    Cite as: Cocco P. Lung cancer and occupation. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 252–265 [https://doi.org/10.1183/2312508X.10035419].

  20. Page 266
    Abstract
    Mark Glover, Hyperbaric Medicine Unit, St Richard's Hospital, Spitalfield Lane, Chichester, PO19 6SE, UK. E-mail: markglover1@nhs.net

    Diving is usually associated with immersion but can include exposure to elevated pressure in a dry environment. The density of compressed gas increases the work of breathing and the elimination of CO2 limits exercise capacity. Respiratory epithelium is often exposed to toxic partial pressures of O2. Immersion redistributes blood and increases the risk of pulmonary oedema, even in apparently healthy individuals. Symptoms in different diving disorders are often very similar, so the equipment used and the circumstances in which a problem occurs frequently contribute significantly towards making a confident diagnosis. A diver can also suffer from a non-diving illness, which should always be included in the differential diagnosis. The most important aspects of respiratory fitness to dive depend on adequate gas flow and exchange to support all reasonably foreseeable physical activity, plus free movement of gas around the respiratory tract to avoid distortion and, in particular, over-distension and rupture of structures which, if damaged, lead to incapacitation or death.

    Cite as: Glover M. Diving. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 266–282 [https://doi.org/10.1183/2312508X.10035519].

  21. Page 283
    Abstract
    Andrew M. Luks, Division of Pulmonary, Critical Care and Sleep Medicine, Harborview Medical Center, 325 Ninth Avenue Box 359762, Seattle, WA 98104, USA. E-mail: aluks@uw.edu

    Hypobaric hypoxia and other environmental changes put people at risk for acute altitude illness and other problems following ascent to high altitude. For people working at high altitude, there is the added challenge of managing the demands of their particular occupation and pre-existing medical problems in a more complex environment. All individuals who travel to high altitude should recognise that hypobaric hypoxia may affect their ability to perform certain types of work. They must also be able to recognise the main forms of acute altitude illness and implement standard pharmacological and nonpharmacological measures for prevention and treatment. Most people with chronic, stable medical conditions can travel to high altitude without difficulty, but environmental factors may create impairments specific to the type of work being performed. Pre-travel counselling can be of use to ensure proper selection of altitude-illness medications, to counsel about the anticipated effects of high altitude on the particular work being performed and on underlying medical problems, and to devise plans to monitor and respond to any complications.

    Cite as: Hebert CJ, Luks AM. Working at high altitude. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 283–300 [https://doi.org/10.1183/2312508X.10035619].

  22. Page 301
    Abstract
    Elaine Fuertes, Emmanuel Kaye Building, 1B Manresa Road, London SW3 6LR, UK. E-mail: e.fuertes@imperial.ac.uk

    Air pollution levels continue to be high worldwide, vary greatly within and between countries, and contribute to a substantial burden of disease. There is convincing evidence that long-term exposure to air pollution adversely affects numerous health outcomes. This chapter presents the recent and growing epidemiological evidence for its effect on respiratory health, focusing on asthma and lung function. Further research should prioritise the pollutant mixtures most detrimental to health and identify the most appropriate health protection measures. Respiratory health is also influenced by outdoor pollen and mould exposures, which are not commonly monitored or regulated by standards. Climate change and interactions with air pollutants influence the growing pattern of outdoor allergens, affecting allergic and asthmatic symptom onset, duration and severity. These changes occur gradually but can result in acute outbreaks of disease, such as thunderstorm-related asthma. While waiting for the implementation of effective controls, there are some limited actions individuals can take to reduce their exposure to air pollution and outdoor allergens.

    Cite as: Fuertes E, Brauer M. The outdoor environment. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 301–316 [https://doi.org/10.1183/2312508X.10035719].

  23. Page 317
    Abstract
    Dennis Nowak, LMU Klinikum, 1 Ziemssenstr. 1, D-80336 München, Germany. E-mail: dennis.nowak@med.uni-muenchen.de

    In industrialised countries, people spend most of their time indoors. Indoor air quality is related to various adverse health effects. Unpleasant humidity and temperature conditions are a frequent matter of dispute. Radon is the primary risk factor for lung cancer in never-smokers and the secondary risk factor in smokers. Dampness and mould are associated with asthma development and exacerbations. Airborne dust and allergens are prevalent in schools and kindergartens. Environmental tobacco smoke still causes premature death and disease in children and nonsmoking adults. Half of the world's population is exposed to health-threatening solid biomass fuel emissions. Sick building syndrome describes a broad range of nonspecific mucosal, skin, respiratory and other symptoms within a particular building, for which personal, individual and constructional factors are responsible. Laser printer emissions that lead to high concentrations of ultrafine particles may cause complaints, but serious adverse health effects have not yet been objectified. So-called aerotoxic syndrome is a heterogeneous condition, the underlying toxicological mechanisms of which are not yet fully understood. Finally, multiple chemical sensitivity is probably related to cognitive emotional problems and not caused by toxicological pathways.

    Cite as: Nowak D, Rakete S, Suojalehto H. Indoor environment. In: Feary J, Suojalehto H, Cullinan P, eds. Occupational and Environmental Lung Disease (ERS Monograph). Sheffield, European Respiratory Society, 2020; pp. 317–334 [https://doi.org/10.1183/2312508X.10035819].